Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism

Antiviral nanoparticle-formulated mimics of heparan sulfate proteoglycans were developed and shown to permit strong viral association as well as inhibition of a range of viruses on in vitro and in vivo models of infection.